Cell proliferation and apoptosis in the immune system in the elderly

Immunologic Research

Volumn 21, Issue 1, 2000, Pages 31-38

  Ginaldi, L ^b   De Martinis, Massimo ^a   D'Ostilio, A ^b   Marini, L ^b   Loreto, M F ^b   Corsi, M P ^b   Quaglino, D ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b NONE

Author keywords

Apoptosis; Cell proliferation; Elderly; Immune system

Indexed keywords

AGED; AGING; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0345420668     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:21:1:31     Document Type: Article

References (65)

1. 1 Franceschi C: Cell proliferation, cell death and aging. Aging 1989;1:3-15.
2. 2 Franceschi C, Monti D, Sansoni P, Cossarizza A: The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995;16:12-16.
3. 3 Quaglino D, Ginaldi L, Furia N, De Martinis M: The effect of age on hemopoiesis. Aging Clin Exp Res 1996;8:1-12.
4. 4 Wakikawa A, Utsuyama M, Hirokawa K: Altered expression of various receptors on T cells in young and old mice after mitogenic stimulation: a flow cytometric analysis. Mech Ageing Dev 1997;94:113-122.
5. 5 Cristofalo VJ, Pignolo R.J: Replicative senescence of human fibroblast-like cells in culture Phisiol 1992;Rev 73:795-808.
6. 6 Cossarizza A, Ortolani C, Monti D, Franceschi C: Cytometric analysis of immunosenescence. Cytometry 1997;27:297-213.
7. 7 Pawelec G, Rehbein A, Haehnel K, Merl A, Adibzadeh M: Human T-cell clones in long-term culture as a model of immunosenescence. Immunol Rev 1997;160: 31-42.
8. 8 Weng N, Palmer LD, Levine BL, Lane HC, June CH, Modes RJ: Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation and aging. Immunol Rev 1997;160:43-54.
9. 9 Pawelec G, Adibzadeh M, Solana R, Beckman I: The T cell in the ageing individual. Mech Ageing Dev 1997;93:35-45.
10. 10 Adibzadeh M, Pohla H, Rehbein A, Pawelec G: Long-term culture of monoclonal human Tlympho-cytes: models for imunosenescence? Mech Ageing Dev 1995;83:171-183.
11. 11 Weng NP, Levine BL, June CH, Hodes RJ: Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 1995;92:11,091-11,094.
12. 12 Effros RB: Insights on immunological aging derived from the T lymphocyte cellular senescence model. Exp Gerontol 1996;31:21-27.
13. 13 Posnett DN, Sinha R, Kahak S, Russo C: Clonal populations of T cells in normal elderly humans -the T cell equivalent to benign monoclonal gammopathy. J Exp Med 1994;179:609-618.
14. 14 Kannerer R, Iten A, Frei PC, Burgisser P: Expansion of T cells negative for CD28 expression in HIV infection. Relation to activation markers and cell adhesio molecules, and correlation with prognostic markers. Med Microbiol Immunol 1996;185:19-25.
15. 15 Rossi E, Matutes E, Morilla R, Owusu-Ankomah K, Heffernan AM, Catovsky D: Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia 1996;10:494-497.
16. 16 Schmidt D, Goronzy JJ, Weyand CM: CD4+ CD7-CD28-T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97:2027-2037.
17. 17 Roman LI, Manzano L, Delahera A, Abreu L, Rossi I, Alvarezmon M: Expanded CD4+ CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease. Gastroenterology 1996;110:1008-1019.
18. 18 Flurkey K, Stadecker M, Miller RA: Memory T lymphocyte hyporesponsiveness to non-cognate stimuli: a key factor in age-related immunodeficiency. Eur J Immunol 1992;22:931-935.
19. 19 Engwerda CR, Handwerger BS, Fox BS: Aged T cells are hyporesponsive to costimulation mediated by CD28. J Immunol 1994;152:3740-3747.
20. 20 Powers DC, Manning MC, Morley JE, Flood IF: Age-related changes in lhymphoproliferation, cytotoxic T lymphocyte responses, and natural killer activity of senescence-accellerated mouse (SAM)-P/8 and SAM-R/1 substrains. Aging Immunol Infect Dis 1995;6:43-52.
21. 21 Utsuyama M, Hirokawa K: Age-related changes of splenic T cells in mice. Flow cytometric analysis. Mech Ageing Dev 1987;40:89-102.
22. + current in a T cell clone by stimulation with anti-CD3 antibody. Cell Signal 1996;8:263-267.
23. 23 Utsuyama M, Wakikawa T, Tamura T, Nariuchi H, Hirokawa K: Impairment of signal transduction in T cells from old mice. Mech Ageing Dev 1997;93:131-144.
24. 24 Franceschi C, Monti D, Sansoni P, Cossarizza A: The immunology of exceptional individual: the lesson of centenarians. Immunol Today 1995;16:12-16.
25. 25 Franceschi C, Monti D, Barbieri DSS, Negro P, Capri M, Guido M, Azzi RPS, Paganelli R, Fagiolo U, Baggio G:, Donazzan S, Mariotti S, D'Addato S, Gaddi A, Ortolani C, Cossarizza A: Immunosenescence in humans: deterioration or remodelling? Int Rev Immunol 1995;12:57-74.
26. 26 Sansoni P, Fagnoni F, Vescovini R, Mazzola M, Brianti V, Bologna G, Nigro E, Lavagetto G, Cossarizza A, Monti D, Franceschi C, Passen M: T lymphocyte proliferative capability to defined stimuli and costimulatory CD28 pathway is not impaired in healthy centenarians. Mech Ageing Dev 1997;96:127-136.
27. 27 Franceschi C, Monti D, Cossarizza A, Fagnoni F, Passeri G, Sansoni P: Aging, longevity and cancer: studies in Down's syndrome and in centenarians. Ann NY Acad Sci 1991;621:428-440.
28. 28 Holt PR, Tierney AR, Kotler DP: Delayed enzyme expression: a defect of aging rat gut. Gastroenterology 1985;89:1026-1034.
29. 29 Holt PR, Yeh KY, Kotler DP: Altered controls of proliferation in proxymal small intestine of the senescent rat. Proc Natl Acad Sci 1988;85:2771-2775.
30. 30 Corazza GR, Ginaldi L, Quaglione G, Ponzielli F, Vecchio L, Biagi F, Quaglino D: Proliferating cell nuclear antigen expression is increased in small bowel epithelium in the elderly. Mech Ageing Dev 1998;104:1-9.
31. 31 Monti D, Troiano L, Grassilli E, Agnesini C, Tropea F, Barbieri D, Capri M, Salvioli S, Ronchetti I, Bellomo G, Cossarizza A, Franceschi C: Cell proliferation and cell death in immunosenescence. Ann NY Acad Sei 1992;663:250-261.
32. 32 Monti D, Grassilli E, Troiano L, Cossarizza A, Salvioli S, Barbieri D, Agnesini C, Bettuzzi S, Ingletti MC, Corti A, Franceschi C: Senescence, immortalization and apoptosis: an intriguing relationship. Ann NY Acad Sci 1992;663:250-261.
33. 33 Cohen JJ: Programmed cell death in the immune system. Adv Immunol 1991;50:55-85.
34. 34 Monti D, Troiano L, Tropea F, Grassilli E, Cossarizza A, Barozzi D, Pelloni MC, Tamassia MG, Franceschi C: Apoptosis - Programmed cell death: a role in the aging process? Am J Clin Nutr 1992;55:1208-1214.
35. 35 Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor family. J Biol Chem 1992;267:10,709-10,715.
36. 36 Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor for tumor necrosis factor. J Exp Med 1989;169:1747-1756.
37. 37 Rathmell JC, Goodnow CC: Effect of the lpr mutation on elimination and inactivation of self-reactive B cells. J Immunol 1994;153:2831-2842.
38. 38 Gamble DA, Schwab R, Weksler ME, Szabo P: Decreased steady-state c-myc mRNA in activated T cell cultures from old humans is caused by a smaller proportion of T cells that transcribe the c-myc gene. J Immunol 1990;144:3569-3573.
39. 39 Pieri C, Recchioni R, Moroni F, Marcheselli F, Lipponi G: Phytohemagglutinin-induced changes of membrane lipid packing, c-myc and c-myb encoded protein expression in human lymphocytes during aging. Mech Ageing Dev 1992;64:177-187.
40. 40 Song I, Stephens JM, Kittur S, Collins GD, Nagel JE, Pekala PH, Adler WH: Mech. Ageing Dev 1992;65:149-156.
41. 41 Venable ME, Lee JY, Smith MJ, Bielawska A, Obeid L: Role of ceramide in cellular senescence. J Biol Chem 1995;270:30,701-30,708.
42. 42 Whisler RL, Liu BQ, Chen M: Age-related decrease in IL-2 production by human Tcells are associated with impaired activation of nuclear transcription factors AP-1 and NF-AT. Cell Immunol 1996;169:185-195.
43. 43 Phelouzat MA, Arbogast A, Laforge T, Quadri RA, Proust JJ: Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence. Mech Ageing Dev 1996;88:25-38.
44. 44 Phelouzat MA, Laforge T, Arbogast A, Quadri RA, Boulet S, Proust JJ: Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of functional Fas receptors. Mech Ageing Dev 1977;96:35-46.
45. 45 Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, Krammer PH: Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 1992;149:3116-3173.
46. 46 Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green D: Cell-autonomous Fas (CD95/Fas-ligand) interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-444.
47. 47 Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994;179:873-879.
48. 48 Alderson MR, Armitage RJ, Maraskovski E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch D: Fas transduces activation signals in normal human T lymphocytes. J Exp Med 1993;178:2231-2235.
49. 49 Oltvai ZN, Korsmeyer SJ: Check-point of dueling dimers foil death wishes. Cell 1994;19:189-192.
50. 50 Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995;16:569-574.
51. 51 Phelouzat MA, Arbogast A, Laforge T. Quadri RA, Proust JJ: Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence. Mech Ageing Dev 1996;88:25-38.
52. 52 Herndon FJ, Hsu HC, Mountz JD: Increased apoptosis of CD45RO T cells with aging. Mech Ageing Dev 1997;94:123-134.
53. 53 Mountz JD, Wu J, Zhou T, Hsu HC: Cell death and longevity: implications of Fas-mediated apoptosis in T-cell senescence. Immunol Rev 1997;160:19-30.
54. 54 Ucker DS, Hebshi LD, Blomquist JF, Toebett BE: Physiological T-cell death: susceptibility is modulated by activation, aging, and transformation, but the mechanism is constant. Immunol Rev 1994;142:273-299.
55. 55 Zhou T, Edwards CK, Mountz JD: Prevention of age-related T cell apoptosis defect in CD2-fas transgenic mice. J Exp Med 1995;182:129-137.
56. 56 Chrest FJ, Bucholz MA, Kim YH, K won TK, Nordin AA: Anti-CD3 induced apoptosis in T cells from young and old mice. Cytometry 1995;20:33-42.
57. 57 Sancar A: DNA repair in humans. Annu Rev Genet 1993;29:69-105.
58. 58 Lazebnik YA, Kaufmann SH, Desnoyers S, Poirler GG, Earnshaw WC:Cleavage of poly(ADP-ribose)polymerase by a proteinase with properties like ICE. Nature 1995;346:346-347.
59. 59 Casciola-Rosen RA, Anhalt GJ, Rosen A: DNA-dependent protein kinase is one of subsets of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995;182:1625-1634.
60. 60 McConnell KR, Dynan WS, Hardin JA: The DNA-dependent protein kinase (p460) is cleaved during Fas-mediated apoptosis in Jurkat cells. J Immunol 1997;158: 2083-2089.
61. 61 Hayflick L: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614-636.
62. 62 Souvannavong V, Lemaire C, Andreau K, Brown S, Adam A: Influence of aging on B-cell apoptosis and expression of the activation marker alkaline phosphatase. Aging Immunol Infect Dis 1996;6:197-207.
63. 63 Wang E: Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res,1995;55:2284-2292.
64. 64 Kane DJ, Saratian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen TE: Bcl-2 inhibition of cell death: decreased generation of reactive oxygen species. Science 1993;262: 1274-1277.
65. 65 Nunez G, Merino R, Grillot D, Gonzales-Garcia M: Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol Today 1994;15:582-588.